Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Common Equity (2016 - 2024)

Historic Common Equity for Qiagen (QGEN) over the last 17 years, with Q3 2025 value amounting to $3.6 billion.

  • Qiagen's Common Equity rose 338.3% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 338.3%. This contributed to the annual value of $3.6 billion for FY2024, which is 631.41% down from last year.
  • Per Qiagen's latest filing, its Common Equity stood at $3.6 billion for Q3 2025, which was up 338.3% from $3.5 billion recorded in Q2 2025.
  • Qiagen's Common Equity's 5-year high stood at $3.8 billion during Q4 2023, with a 5-year trough of $2.8 billion in Q1 2021.
  • Its 5-year average for Common Equity is $3.4 billion, with a median of $3.5 billion in 2022.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 3028.19% in 2021, then crashed by 631.41% in 2024.
  • Quarter analysis of 5 years shows Qiagen's Common Equity stood at $3.1 billion in 2021, then rose by 11.95% to $3.5 billion in 2022, then increased by 9.84% to $3.8 billion in 2023, then fell by 6.31% to $3.6 billion in 2024, then grew by 2.3% to $3.6 billion in 2025.
  • Its Common Equity stands at $3.6 billion for Q3 2025, versus $3.5 billion for Q2 2025 and $3.4 billion for Q1 2025.